Article Dans Une Revue EuPA Open Proteomics Année : 2016

Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics

Résumé

The growing understanding of the molecular mechanisms underlying epithelial-to-mesenchymal transition (EMT) may represent a potential source of clinical markers. Despite EMT drivers have not yet emerged as candidate markers in the clinical setting, their association with established clinical markers may improve their specificity and sensitivity. Mass spectrometry-based platforms allow analyzing multiple samples for the expression of EMT candidate markers, and may help to diagnose diseases or monitor treatment efficiently. This review highlights proteomic approaches applied to elucidate the differences between epithelial and mesenchymal tumors and describes how these can be used for target discovery and validation.

Fichier principal
Vignette du fichier
1-s2.0-S2212968516300034-main.pdf (1.01 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence
Loading...

Dates et versions

inserm-02940397 , version 1 (16-09-2020)

Licence

Identifiants

Citer

Daniele Vergara, Pasquale Simeone, Julien Franck, Marco Trerotola, Anna Giudetti, et al.. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. EuPA Open Proteomics, 2016, 10, pp.31-41. ⟨10.1016/j.euprot.2016.01.003⟩. ⟨inserm-02940397⟩
183 Consultations
242 Téléchargements

Altmetric

Partager

  • More